Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

未开盘 09-19 16:00:00 EDT

0.9607

-0.0393

-3.93%

盘后0.9899

+0.0292+3.04%

17:59 EDT

最高1.02	最低0.9606	成交量10.93万
今开1.00	昨收1.00	日振幅5.94%
总市值245.19万	流通市值245.03万	总股本255.22万
成交额10.72万	换手率4.28%	流通股本255.05万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":0.9607,"timestamp":1726776000000,"preClose":1,"halted":0,"volume":109259,"hourTrading":{"tag":"盘后","latestPrice":0.9899,"preClose":0.9607,"latestTime":"17:59 EDT","volume":4883,"amount":4691.8764,"timestamp":1726783146035},"delay":0,"floatShares":2550500,"shares":2552190,"eps":-13.740521,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.0393,"latestTime":"09-19 16:00:00 EDT","open":1,"high":1.02,"low":0.9606,"amount":107216.0315144,"amplitude":0.0594,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.740521,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726819200000},"adr":0,"adjPreClose":1,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.9891,"preClose":1,"latestTime":"08:44 EDT","volume":5301,"amount":5143.7702196,"timestamp":1726749860879},"postHourTrading":{"tag":"盘后","latestPrice":0.9899,"preClose":0.9607,"latestTime":"17:59 EDT","volume":4883,"amount":4691.8764,"timestamp":1726783146035},"volumeRatio":1.584911,"impliedVol":6.8861,"impliedVolPercentile":0.9908},"requestUrl":"/m/hq/s/BPTH","defaultTab":"news","newsList":[{"id":"2461347666","title":"Bio-Path Holdings, Inc.2024财年第二财季实现净利润-1.87百万美元，同比增加55.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461347666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461347666?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:00","pubTimestamp":1724342424,"startTime":"0","endTime":"0","summary":"8月23日，Bio-Path Holdings, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.87百万美元，同比增加55.79%；其中营业收入为0.00美元，每股基本收益为-1.16美元。从资产负债表来看，Bio-Path Holdings, Inc.总负债3.83百万美元，其中短期债务55000.00美元，资产负债比为1.34，流动比率为1.67。机构评级：截至2024年8月23日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为20.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408230000289f4898b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408230000289f4898b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH"],"gpt_icon":0},{"id":"2461493874","title":"BUZZ--美国股票走势-皮博迪能源公司、雪花公司、托尔兄弟公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461493874","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461493874?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:14","pubTimestamp":1724264082,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月21日 - 标普500指数和纳斯达克指数周三走高，原因是美国截至2024年3月底的就业数据大幅向下修正，表明劳动力市场放缓，支撑了美联储下月降息的希望。美东时间13:36，道琼斯工业平均指数  上涨0.05%，报40,856.99点。标普500指数  上涨0.25%，报5611.22点；纳斯达克综合指数  上涨0.27%，报17864.627点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WWD",".DJI","SDOW","GLW","TWFG","BTU","DOG","BUZZ","BPTH","BK4533","TJX","WKHS","BK4554","MNQmain","NEM","SQQQ","ADI","DDM","PAGS","AXP","CRC","DJX","NNOX","TXN","KEYS","QLD","H",".IXIC","PRCT","PX","M","QID","TQQQ","DXD","PSQ","NQmain","UDOW","ARCH","COTY","AADI","TOL","LU0109392836.USD","CEIX","F","SNOW"],"gpt_icon":1},{"id":"2461891826","title":"BUZZ--美国股票走势-模拟器件、TJX、德州仪器","url":"https://stock-news.laohu8.com/highlight/detail?id=2461891826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461891826?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:25","pubTimestamp":1724246707,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月21日 - 华尔街主要股指周三将高开，因为投资者在等待美国最新的就业数据和美联储7月份政策会议纪要的公布。.美东时间9:06，道指电子盘  上涨0.17%，报41,018点。标普500指数小型股  上涨0.19%，报5630.5点；纳斯达克100指数小型股  上涨0.19%，报19846.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","M","BK4587","LU2552382058.USD","LU0312595415.SGD","LU0310800965.SGD","BK4141","LU1674673691.USD","LU2458330243.SGD","PX","LU0557290698.USD","LU2237443622.USD","BK4561","LU0211328371.USD","LU1244550221.USD","GLW","CEIX","F","LU1003077747.HKD","IE00B5949003.HKD","LU2237443978.SGD","SG9999003800.SGD","LU1066053197.SGD","SDIG","LU2023250504.SGD","LU1803068979.SGD","TXN","BK4585","LU2552382215.SGD","BPTH","AADI","LU0011850046.USD","ARCH","BUZZ","AXP","WKHS","LU2237443549.SGD","TJX","LU1674673428.USD","KEYS","NNOX","WWD","LU2552382132.HKD","ADI","COTY","IE0004445015.USD","LU2458330169.SGD","BK4196"],"gpt_icon":1},{"id":"2461985842","title":"BUZZ-实验性抗癌药物在正在进行的试验中显示出前景，Bio-Path 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2461985842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461985842?lang=zh_cn&edition=full","pubTime":"2024-08-21 19:50","pubTimestamp":1724241046,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月21日 - ** Bio-Path控股公司  股价盘前上涨12.8%至1.67美元** 药物开发商称，在一项正在进行的针对一种血癌的中期试验中，使用其实验性药物prexigebersen的联合疗法延长了治疗的持久性** 该公司还表示，在一项正在进行的早期研究中，其另一种癌症候选药物 BP1001-A 在首例服用较高剂量药物的患者身上出现了肿瘤消退现象** 截至上一交易日收盘，该公司股价年累计下跌 84","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BPTH","BK4139"],"gpt_icon":0},{"id":"2461882112","title":"Bio-Path Holdings, Inc.盘中异动 下午盘股价大跌5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461882112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461882112?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:24","pubTimestamp":1724174646,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时24分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫5.33%。截至发稿，该股报1.42美元/股，成交量1.0552万股，换手率0.41%，振幅6.00%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821012407971995a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821012407971995a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2459210608","title":"Bio-Path Holdings, Inc.盘中异动 早盘快速拉升5.37%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210608","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210608?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:00","pubTimestamp":1723816802,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时00分，Bio-Path Holdings, Inc.股票出现异动，股价急速上涨5.37%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3813.84%、1449.13%、162.10%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.、Cingulate Inc.，振幅分别为100.53%、36.81%、35.42%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220002959ef26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220002959ef26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2459236193","title":"Bio Path 控股公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459236193","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459236193?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:29","pubTimestamp":1723771751,"startTime":"0","endTime":"0","summary":"   * Bio Path Holdings Inc   报告，截至6月底的季度调整后每股亏损1.16美元，高于去年同期的每股收益10.60美元。分析师对该季度的唯一预测是每股亏损 1.54 美元。* Bio Path 控股公司本季度报告的每股收益为亏损 1.16 美元。* 该公司当季亏损 187 万美元。* Bio Path Holdings Inc 本季度股价下跌了 24.5%，今年迄今为止下跌了 83.7%。8月16日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 25.2%。华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bio Path 控股公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2459189852","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘急速上涨8.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189852","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189852?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:50","pubTimestamp":1723564231,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时50分，Bio-Path Holdings, Inc.股票出现波动，股价大幅拉升8.40%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为134.48%、127.54%、32.93%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为68.92%、40.95%、39.71%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235031af974425&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235031af974425&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2459907806","title":"Bio Path Holdings Inc   预计每股亏损1.54美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2459907806","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459907806?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:27","pubTimestamp":1723559258,"startTime":"0","endTime":"0","summary":"   * Bio Path Holdings Inc    将于8月15日公布截至2024年6月30日的财报，预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Bio Path Holdings Inc 每股亏损 1.54 美元。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Bio Path Holdings Inc 的 12 个月目标价中位数为 20.00 美元，高于其上一次收盘价 1.31 美元。8月13日 - 本摘要于北京时间 8 月 13 日 14:27 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bio Path Holdings Inc   预计每股亏损1.54美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPTH"],"gpt_icon":0},{"id":"2458289989","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458289989","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458289989?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:56","pubTimestamp":1723470997,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时56分，Bio-Path Holdings, Inc.股票出现异动，股价大幅跳水5.63%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Oragenics Inc.、Revance Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为54.32%、31.88%、11.58%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.，振幅分别为40.71%、26.33%、23.72%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221563896825bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221563896825bd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2458516121","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458516121","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458516121?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:19","pubTimestamp":1723220370,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时19分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨5.55%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为415.14%、87.48%、65.33%，振幅较大的相关个股有Azitra Inc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为90.93%、62.57%、37.04%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001931968257c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001931968257c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2457030720","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457030720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457030720?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864749,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Bio-Path Holdings, Inc.股票出现异动，股价快速下挫6.88%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为979.96%、34.05%、13.54%，振幅较大的相关个股有Cue Biopharma, Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为12.33%、12.19%、11.60%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213229af95fa09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213229af95fa09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2456430243","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456430243","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456430243?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:36","pubTimestamp":1722526563,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时36分，Bio-Path Holdings, Inc.股票出现波动，股价急速下跌5.06%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为431.14%、331.74%、204.99%，振幅较大的相关个股有Immuneering Corporation、Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为42.48%、41.85%、40.35%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123360398e34b1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123360398e34b1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2455195771","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.82%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455195771","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455195771?lang=zh_cn&edition=full","pubTime":"2024-07-31 00:16","pubTimestamp":1722356161,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日00时16分，Bio-Path Holdings, Inc.股票出现波动，股价快速跳水5.82%。截至发稿，该股报1.62美元/股，成交量4.0691万股，换手率1.96%，振幅6.39%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731001601956ddf95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731001601956ddf95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2452439754","title":"Bio-Path Holdings, Inc.盘中异动 快速下挫7.77%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439754","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452439754?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:57","pubTimestamp":1721318265,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时57分，Bio-Path Holdings, Inc.股票出现异动，股价急速跳水7.77%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为2.17%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2253.31%、2145.68%、1183.91%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235746aefa5a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235746aefa5a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2451181689","title":"Bio-Path Holdings, Inc.盘中异动 早盘大幅拉升5.63%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451181689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451181689?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:04","pubTimestamp":1721138687,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时04分，Bio-Path Holdings, Inc.股票出现波动，股价快速拉升5.63%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1800.08%、1035.25%、96.35%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.19%、39.04%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716220448aef9f5a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716220448aef9f5a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2451962270","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘股价大跌5.61%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451962270","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451962270?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:36","pubTimestamp":1721057760,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时36分，Bio-Path Holdings, Inc.股票出现异动，股价大幅跳水5.61%。截至发稿，该股报1.85美元/股，成交量1.7045万股，换手率0.82%，振幅7.65%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152336009f4fae5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152336009f4fae5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2450534860","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450534860","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450534860?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:40","pubTimestamp":1720795227,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时40分，Bio-Path Holdings, Inc.股票出现异动，股价快速拉升5.31%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Soligenix, Inc.较为活跃，换手率分别为2590.08%、89.92%、49.86%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为147.88%、48.15%、47.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712224027aef97d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712224027aef97d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2450985842","title":"Bio-Path Holdings, Inc.盘中异动 下午盘快速上涨7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450985842","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450985842?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:16","pubTimestamp":1720639007,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时16分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨7.93%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Kazia Therapeutics Limited、Uniqure N.V.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为4194.87%、1582.50%、1391.22%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为421.88%、156.03%、133.16%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110316489681b99b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110316489681b99b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2450073372","title":"Bio-Path Holdings, Inc.盘中异动 急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450073372","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450073372?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:51","pubTimestamp":1720543891,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时51分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.03%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Soligenix, Inc.、180 Life Sciences Corp.、Uniqure N.V.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为10229.02%、2549.08%、332.41%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为327.50%、196.29%、134.00%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005131941f57a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005131941f57a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":-0.3333},{"period":"3month","weight":-0.5652},{"period":"6month","weight":-0.7704},{"period":"1year","weight":-0.8757},{"period":"ytd","weight":-0.892}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0032},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0771},{"period":"1year","weight":0.2681},{"period":"ytd","weight":0.1811}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.053526},{"month":6,"riseRate":0.545455,"avgChangeRate":0.01417},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.105842},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.169267},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.082711},{"month":10,"riseRate":0.6,"avgChangeRate":0.094767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.112549},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}